Oncotarget is a favorite, online website that publishes scientific journals. It focuses on issues related to cancer, and the online medical journal is also posting information about the disease and how to fight it. The online medical journal first published an article in 2010, and since then, many scientists around the world started using Oncotarget for publication purposes. It became popular through the years and has been the number one source for cancer-related articles. Oncotarget is now transforming to become an extensive, online resource tool that can be used by scientists around the world, and one of the advantages of the online medical journal is its open-access platform and the ability of other scientists around the world to review each article after being posted. Check the journal at SCImago Journal & Country Rank.
Oncotarget is written in English, and it is under the umbrella of Impact Journals. Dr. Mikhail Blagosklonny and Andrei V. Gudkov, two of the leading oncologists on the planet, serve as the online medical journal’s editors in chief. The two are working at the Roswell Park Cancer Institute as researchers and professors, but they have also shown their passion for writing scientific journals about cancer. Dr. Mikhail Blagosklonny is also known in the scientific field as the man who tries to discover the key to immortality, as he is presently experimenting with rapamycin and unlocking its potential to fight aging. Andrei V. Gudkov, on the other hand, is practicing oncology and cardiology at the same time. They are monitoring Oncotarget since its release in 2010, and they have already made so many changes and improvements to the online medical journal. Since 2017, the online medical journal has been releasing two articles per week, and the reason behind it was the massive number of people who are visiting the website demanding for more articles to read. Oncotarget also includes a handful of written reports that do not focus on cancer, and they are targeting to become the leading online medical journal for all kinds of diseases in the coming years.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/
Recently, the Frontiers in Cancer Science conference was held in Singapore. Oncotarget sent some of the best researchers in the field of biomedicine to Singapore to attend the event, and they presented the advancement with treating cancer and ways on how to fight it. The presentation was lauded by other scientists around the world, citing that Oncotarget is helpful in opening communications between scientists and working together to achieve a single goal. Learn more about Oncotarget at Eurekalert.org.